The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current revenue (TTM ) is โน2.855 Trillion. an increase over the revenue in the year 2023 that were of โน2.346 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โน2.867 T | 22.18% |
2023 | โน2.346 T | 7.74% |
2022 | โน2.178 T | 12.65% |
2021 | โน1.933 T | 4% |
2020 | โน1.859 T | 11.61% |
2019 | โน1.665 T | 0.33% |
2018 | โน1.660 T | 13.81% |
2017 | โน1.458 T | -6.62% |
2016 | โน1.562 T | 8.53% |
2015 | โน1.439 T | 13.21% |
2014 | โน1.271 T | 10.21% |
2013 | โน1.153 T | 22.06% |
2012 | โน945.31 B | 14.68% |
2011 | โน824.28 B | 22.2% |
2010 | โน674.52 B | -0.72% |
2009 | โน679.38 B | -5.79% |
2008 | โน721.11 B | 24.4% |
2007 | โน579.68 B | -8.27% |
2006 | โน631.92 B | 12.98% |
2005 | โน559.35 B | 22.42% |
2004 | โน456.89 B | 20.1% |
2003 | โน380.43 B | 45.75% |
2002 | โน261.01 B | 36.67% |
2001 | โน190.98 B | 17.23% |
2000 | โน162.91 B | 16.96% |
1999 | โน139.29 B | 23.98% |
1998 | โน112.35 B | 21.87% |
1997 | โน92.18 B | 16.66% |
1996 | โน79.02 B |